Home/Filings/4/0000899243-22-025626
4//SEC Filing

Barton Debora 4

Accession 0000899243-22-025626

CIK 0001783328other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 7:57 AM ET

Size

5.5 KB

Accession

0000899243-22-025626

Insider Transaction Report

Form 4
Period: 2022-07-05
Barton Debora
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-07-05+150,000150,000 total
    Exercise: $3.17Exp: 2032-07-04Voting Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following July 5, 2022, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the Issuer.

Issuer

TScan Therapeutics, Inc.

CIK 0001783328

Entity typeother

Related Parties

1
  • filerCIK 0001936730

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 7:57 AM ET
Size
5.5 KB